- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Monday, 20 May 2013
-
Current Status:
Answered by Alex Neil on 5 June 2013
To ask the Scottish Government what the pay banding is for perfusionists in Scotland and what information it has on the pay bandings in (a) England and (b) Wales.
Answer
There are a range of job profiles available for perfusionist staff in Scotland from Band 5 to Band 8c, the banding outcome is dependent on job profiles. We understand there are a similar range of profiles for the post in England and Wales.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Monday, 20 May 2013
-
Current Status:
Answered by Alex Neil on 5 June 2013
To ask the Scottish Government how many locum perfusionists each NHS board has employed and at what cost, in each year since 2007-08.
Answer
The information requested on how many locum perfusionists employed by each NHS board and at what cost is not centrally held.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Monday, 20 May 2013
-
Current Status:
Answered by Alex Neil on 5 June 2013
To ask the Scottish Government how many NHS perfusionists are due to retire in the next five years.
Answer
In accordance with current legislation we can no longer presume a retiral age as this is discriminatory. Information relating to the numbers of NHS perfusionists retiring in the next five years is not, therefore available.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Monday, 20 May 2013
-
Current Status:
Answered by Alex Neil on 5 June 2013
To ask the Scottish Government whether any NHS board has a recruitment and retention premium for perfusionists.
Answer
NHS Lothian currently has a recruitment and retention premium in place for its clinical perfusionist staff.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Tuesday, 28 May 2013
-
Current Status:
Answered by John Swinney on 4 June 2013
To ask the Scottish Government what plans it has to consult on a replacement for council tax benefit.
Answer
Working in partnership with local government, we responded quickly to put in place transitional arrangements to ensure that around 560,000 people in Scotland who were receiving council Tax benefit are protected from the UK Government’s 10% cut in successor arrangement funding.
We are currently in discussion with our Local Government partners and other stakeholders on arrangements for future years beyond 2013-14. The UK Government’s introduction of Universal Credit in October 2013 and its operation will have significant implications for how future council tax support may be provided.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Monday, 03 June 2013
-
Current Status:
Taken in the Chamber on 6 June 2013
To ask the First Minister what the Scottish Government's position is on recruitment and retention payments paid to senior management at the State Hospital.
Answer
Taken in the Chamber on 6 June 2013
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Tuesday, 28 May 2013
-
Current Status:
Answered by John Swinney on 3 June 2013
To ask the Scottish Government whether it will fully fund the replacement for council tax benefit beyond April 2014.
Answer
I refer the member to the answer to question S4W-14493 on 3 May 2013. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at:
http://www.scottish.parliament.uk/parliamentarybusiness/28877.aspx.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 16 May 2013
-
Current Status:
Answered by Alex Neil on 3 June 2013
To ask the Scottish Government, further to the answer to question S4W-12535 by Alex Neil on 27 February 2013, how many meetings have been held and who attended each meeting.
Answer
The on-going negotiations on the replacement to the current Pharmaceutical Price Regulation Scheme involve the UK Government and Association of British Pharmaceutical Industry.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 16 May 2013
-
Current Status:
Answered by Alex Neil on 3 June 2013
To ask the Scottish Government, further to the answer to question S4W-13806 by Alex Neil on 15 April 2013 and in light of paragraphs 5.14 and 5.15 of the code of conduct, whether it considers it appropriate for a member of Health Improvement Scotland's board not to register the employment of a family member in the organisation as a potential conflict of interest, and what the reasons are for its position on this matter.
Answer
All members of NHS boards are expected to carry out their responsibilities in line with the board members’ code of conduct. The Scottish Government expects board members to take responsibility for ensuring that the register of interests is accurate, and for board chairs to hold members to the code of conduct. The register of interests is reviewed by the external auditor when annual accounts are submitted.
Healthcare Improvement Scotland is currently updating its register of interests as part of its annual accounts process.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 16 May 2013
-
Current Status:
Answered by Alex Neil on 3 June 2013
To ask the Scottish Government what action it is taking to raise awareness of the long-term organ damage that can be caused by misuse of painkillers.
Answer
The safety of medicines is currently a reserved matter with the Medicines and Healthcare products Regulatory Agency (MHRA) having responsibility across the UK.
I understand from the MHRA that information on possible side effects which may occur in association with use of painkillers, including where appropriate effects associated with long term use and risk of overdose, are outlined in the information associated with the medicines and provided to healthcare professionals (the Summary of Product Characteristics) and patients (Patient Information Leaflet).
Painkillers that are available as over the counter medicines are subject to restrictions on pack size. There are clear warnings on the outer packaging of these products that the stated dose should not be exceeded and they should not be used to control symptoms for longer than three days without medical advice. There is also clear advice that if the symptoms persist then the individual should consult their doctor.
Medicines containing paracetamol contain a warning about the risk of serious liver damage if the dose is exceeded.